The absorption of pyridoxine from the intestine of the mouse was studied in whole animals.
Pyridoxine (PN) is the form of vitamin B6 found in foods from plant sources (1) and is the form most commonly used in vitamin supplements. Therefore, the transport and metabolism of PN to the active coenzyme (pyridoxal phosphate, PLP) in the various organs and tissues are important elements in the management of this nutrient.
The general pathway for the conversion of PN to PLP is well known. Briefly, PN is phosphorylated to pyridoxine phosphate (PNP) by pyridoxal (PL) kinase which has been detected in all mammalian tissues investigated (2). PNP is converted to PLP by PNP oxidase (3) which, in contrast to the wide distribution of PL kinase, is confined to a few tissues (4, 5). PLP can be trasformed to pyridoxamine phosphate (PMP) by enzymatic transamination or hydrolyzed to PL by phosphatases (6). PL is then converted to pyridoxic acid by aldehyde oxidase (5) or again to PLP by PL Results from studies with perfused liver and intestinal rings indicated that PN was rapidly taken up by these tissues, phosphorylated to PNP by PL kinase and Vol. 34, No. 2, 1988 then converted to PLP by PNP oxidase (7, 8). These two enzymes plus phosphatases may provide a means of converting dietary PN to circulating PL. In fact, it was found that the newly formed PLP in perfused liver(7) and isolated hepatocytes (9) was considerably converted to PL and released into the perfusate or the medium. Moreover, our recent study has shown that when a physiological dose of PN is orally given to mouse, PN is completely converted to circulating PL, and thus the PL may be used as a principal source of vitamin B6 for most tissues (10).
A problem as to which organ, intestine or liver, participates mainly in the conversion of PN into PL remains to be clarified. The purpose of the present study is to evaluate the participation of intestine in the conversion of dietary PN to circulating PL, analyzing metabolites of PN in portal and peripheral blood following oral administration of PN.
MATERIALS AND METHODS
Chemicals.
[ perfused intestine, observed that PN was somewhat transformed to PNP but not other B6 vitamers including PLP, and concluded that PNP oxidase was not present in the intestine, the activity in metabolism of PN in the perfused intestine appeared to compare unfavorably with that in the intestinal rings described above. The observation that most [3H]PL in the portal blood is located in the plasma (Fig. 2a) suggests that the plasma PL may be the major source of PLP for most tissues including liver tissue, and that the loose binding of PL to plasma al bumin (16) and the resulting accumulation of the vitamer in the plasma may provide a means for PL to function as a principal transport form in the blood (Fig. 3) .
When amounts of [3H]PN larger than 46 nmol were administered, a consider able amount of [3H]PN appeared in both the portal and peripheral blood without being perfectly transformed to [3H]PL (Fig. 1, c and d) . This result suggests that the ability of intestine to perfectly convert dietary PN to circulating PL has a limit and the limit is between 14 and 46 nmol of PN per mouse. The PN leaked out to the portal circulation was practically located in the plasma. The plasma PN may be able to serve as a source of the coenzyme PLP in some tissues that contain both PL kinase and PNP oxidase.
Relative ratios of [3H]PN to all the 3H-B6 vitamers in both the portal and peripheral blood were calculated from the chromatograms in Fig. 1, a, b, c , and d. When [3H]PN up to 14 nmol/mouse was administered, the ratios in the portal blood were very small and almost similar to those of the peripheral blood. If, however, [3H]PN more than 46 nmol/mouse was administered, the ratios in the portal blood surpassed those in the peripheral blood (Fig. 4) . The differences between the portal and peripheral blood in these ratios possibly resulted from participation of the liver in the conversion of PN to PL.
Thus, it is important to note that when a physiological level of PN is orally administered to mice, PN is almost entirely transformed to PL in the intestine which may be the major source of vitamin B6 for most tissues and organs including the blood and liver, and that even when a large quantity of PN is administered, a considerable amount of PL in the blood is originated from the PL produced by the intestine.
